SML3644

JR-AB2-011

≥98% (HPLC)

• Synonym(e): 3-(3,4-Dichlorophenyl)-1-(4-fluorophenyl)-1-(5-methyl-4,5-dihydrothiazol-2-yl)urea, N-(3,4-Dichlorophenyl)-2-[(4-fluorophenyl)imino]-5-methyl-3-thiazolidinecarboxamide
• Empirische Formel (Hill-System): C₁₇H₁₄Cl₂FN₃OS
• CAS-Nummer: 2411853-34-2
• Molekulargewicht: 398.28
• UNSPSC Code: 12352200
• NACRES: NA.77
• MDL number: MFCD32062799
• Assay: ≥98% (HPLC)
• Form: powder

Eigenschaften

• Quality Segment: 100
• assay: ≥98% (HPLC)
• form: powder
• color: white to beige
• solubility: DMSO: 2 mg/mL, clear (Warmed)
• storage temp.: 2-8°C

Beschreibung

Biochem/physiol Actions

JR-AB2-011 is a selective mTORC2 inhibitor that blocks the interaction of Rictor and mTOR (IC50 = 0.31 µM) without affecing mTORC1 activity or assembly. JR-AB2-011 exhibits anti-glioblastoma (GBM) activity in vitro (proliferation IC50 = 0.31 µM post 72h treatment, 36.3% apoptosis post 48h 1 µM treatment in LN229 cultures) and in vivo (4 or 20 mg/kg/d i.p. to LN229 xenografted mice).

Selective mTORC2 inhibitor with anti-GBM efficacy in vitro and in vivo by blocking Rictor and mTOR interaction.

Sicherheitshinweise

• Lagerklasse: 11 - Combustible Solids
• wgk: WGK 3
• flash_point_f: Not applicable
• flash_point_c: Not applicable